Bhumi Pharmaceuticals — Mebendazole Exporter Profile
Indian Pharmaceutical Exporter · #15 for Mebendazole · $158.3K export value · DGFT Verified
Bhumi Pharmaceuticals is the #15 Indian exporter of Mebendazole with $158.3K in export value and 24 verified shipments. Bhumi Pharmaceuticals holds a 1.2% market share in Mebendazole exports across 3 countries. The company exports 2 pharmaceutical products worth $1.5M across 2 therapeutic categories.
Bhumi Pharmaceuticals — Mebendazole Export Profile: Buyers & Destinations
Where Does Bhumi Pharmaceuticals Export Mebendazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| LIBERIA | $145.3K | 20 | 91.8% |
| ANGOLA | $9.5K | 2 | 6.0% |
| SOMALIA | $3.4K | 2 | 2.2% |
Bhumi Pharmaceuticals exports Mebendazole to 3 countries. The largest destination is LIBERIA accounting for 91.8% of Bhumi Pharmaceuticals's Mebendazole shipments, followed by ANGOLA (6.0%) and SOMALIA (2.2%). These destinations reflect Bhumi Pharmaceuticals's established distribution network and regulatory approvals in key markets.